TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/18/25 16:30 | 7/16/25 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Goldan Keith A. | NY | O | CFO | S | -12 | 9.29 | 0 | -1 | -1 | 92 | D | ||||||||||||||
5/19/25 16:04 | 5/19/25 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Goldan Keith A. | NY | O | CFO | P | 0 | 0.00 | 0 | 3 | 3 | 94 | D | ||||||||||||||
2/12/25 17:16 | 2/10/25 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Goldan Keith A. | MA | O | CFO | S | -59 | 15.50 | 0 | -4 | -4 | 91 | D | ||||||||||||||
6/17/24 09:26 | 6/14/24 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Goldan Keith A. | MA | O | CFO | P | 25 | 20.03 | 0 | 1 | 2 | 53 | D | ||||||||||||||
6/14/23 16:20 | 6/13/23 | SNDX | Syndax Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Goldan Keith A. | MA | O | CFO | S | -13 | 22.31 | 0 | -1 | -18 | 3 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |